RFK Jr. Comments on AI's Potential Impact on FDA Regulation
RFK Jr. stated during congressional hearings that AI could render the FDA 'irrelevant' by enabling the development of new drugs and personalized medicine. His comments highlight concerns about the regulatory challenges posed by rapid AI advancements in healthcare.
Topics: AI FDA Healthcare Regulation RFK Jr.